Terms: = Brain cancer AND ER, estrogen receptor AND Clinical Outcome
19 results:
1. Characterisation of the immune microenvironment of primary breast cancer and brain metastasis reveals depleted T-cell response associated to ARG2 expression.
Giannoudis A; Varešlija D; Sharma V; Zakaria R; Platt-Higgins A; Rudland PS; Jenkinson MD; Young LS; Palmieri C
ESMO Open; 2022 Dec; 7(6):100636. PubMed ID: 36423363
[TBL] [Abstract] [Full Text] [Related]
2. Identification of thioredoxin domain containing family members' expression pattern and prognostic value in diffuse gliomas via in silico analysis.
Kocatürk B
Cancer Med; 2023 Feb; 12(3):3830-3844. PubMed ID: 36106447
[TBL] [Abstract] [Full Text] [Related]
3. Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress.
Liu X; Viswanadhapalli S; Kumar S; Lee TK; Moore A; Ma S; Chen L; Hsieh M; Li M; Sareddy GR; Parra K; Blatt EB; Reese TC; Zhao Y; Chang A; Yan H; Xu Z; Pratap UP; Liu Z; Roggero CM; Tan Z; Weintraub ST; Peng Y; Tekmal RR; Arteaga CL; Lippincott-Schwartz J; Vadlamudi RK; Ahn JM; Raj GV
Nat Cancer; 2022 Jul; 3(7):866-884. PubMed ID: 35654861
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014).
De Lara S; Nyqvist J; Werner Rönnerman E; Helou K; Kenne Sarenmalm E; Einbeigi Z; Karlsson P; Parris TZ; Kovács A
BMC Cancer; 2019 Feb; 19(1):187. PubMed ID: 30819139
[TBL] [Abstract] [Full Text] [Related]
5. Continued Endocrine Therapy Is Associated with Improved Survival in Patients with Breast cancer brain Metastases.
Bergen ES; Berghoff AS; Medjedovic M; Rudas M; Fitzal F; Bago-Horvath Z; Dieckmann K; Mader RM; Exner R; Gnant M; Zielinski CC; Steger GG; Preusser M; Bartsch R
Clin Cancer Res; 2019 May; 25(9):2737-2744. PubMed ID: 30647078
[TBL] [Abstract] [Full Text] [Related]
6. Therapeutic Potentials of BDNF/TrkB in Breast cancer; Current Status and Perspectives.
Tajbakhsh A; Mokhtari-Zaer A; Rezaee M; Afzaljavan F; Rivandi M; Hassanian SM; Ferns GA; Pasdar A; Avan A
J Cell Biochem; 2017 Sep; 118(9):2502-2515. PubMed ID: 28230291
[TBL] [Abstract] [Full Text] [Related]
7. 70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast cancer.
Cardoso F; van't Veer LJ; Bogaerts J; Slaets L; Viale G; Delaloge S; Pierga JY; Brain E; Causeret S; DeLorenzi M; Glas AM; Golfinopoulos V; Goulioti T; Knox S; Matos E; Meulemans B; Neijenhuis PA; Nitz U; Passalacqua R; Ravdin P; Rubio IT; Saghatchian M; Smilde TJ; Sotiriou C; Stork L; Straehle C; Thomas G; Thompson AM; van der Hoeven JM; Vuylsteke P; Bernards R; Tryfonidis K; Rutgers E; Piccart M;
N Engl J Med; 2016 Aug; 375(8):717-29. PubMed ID: 27557300
[TBL] [Abstract] [Full Text] [Related]
8. Sexual dimorphism in medulloblastoma features.
Zannoni GF; Ciucci A; Marucci G; Travaglia D; Stigliano E; Foschini MP; Scambia G; Gallo D
Histopathology; 2016 Mar; 68(4):541-8. PubMed ID: 26132417
[TBL] [Abstract] [Full Text] [Related]
9. Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
Berghoff AS; Bartsch R; Preusser M; Ricken G; Steger GG; Bago-Horvath Z; Rudas M; Streubel B; Dubsky P; Gnant M; Fitzal F; Zielinski CC; Birner P
Breast; 2014 Oct; 23(5):637-43. PubMed ID: 25017122
[TBL] [Abstract] [Full Text] [Related]
10. Heterogeneity in the expression of receptors in the human breast cancer metastasized to the brain.
Rao PS; Labhart M; Mayhew SL; Thirumala S; Rao US
Tumour Biol; 2014 Jul; 35(7):7267-73. PubMed ID: 24777335
[TBL] [Abstract] [Full Text] [Related]
11. Nuclear T-STAR protein expression correlates with HER2 status, hormone receptor negativity and prolonged recurrence free survival in primary breast cancer and decreased cancer cell growth in vitro.
Sernbo S; Borrebaeck CA; Uhlén M; Jirström K; Ek S
PLoS One; 2013; 8(7):e70596. PubMed ID: 23923007
[TBL] [Abstract] [Full Text] [Related]
12. The shifting landscape of metastatic breast cancer to the CNS.
Quigley MR; Fukui O; Chew B; Bhatia S; Karlovits S
Neurosurg Rev; 2013 Jul; 36(3):377-82. PubMed ID: 23262837
[TBL] [Abstract] [Full Text] [Related]
13. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
Ben-Porath I; Thomson MW; Carey VJ; Ge R; Bell GW; Regev A; Weinberg RA
Nat Genet; 2008 May; 40(5):499-507. PubMed ID: 18443585
[TBL] [Abstract] [Full Text] [Related]
14. The pattern of clinical breast cancer metastasis correlates with a single nucleotide polymorphism in the C1qA component of complement.
Racila E; Racila DM; Ritchie JM; Taylor C; Dahle C; Weiner GJ
Immunogenetics; 2006 Feb; 58(1):1-8. PubMed ID: 16465510
[TBL] [Abstract] [Full Text] [Related]
15. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling.
Workie DW; Dardzinski BJ; Graham TB; Laor T; Bommer WA; O'Brien KJ
Magn Reson Imaging; 2004 Nov; 22(9):1201-10. PubMed ID: 15607091
[TBL] [Abstract] [Full Text] [Related]
16. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract] [Full Text] [Related]
17. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.
Zunarelli E; Nicoll JA; Migaldi M; Trentini GP
Breast Cancer Res Treat; 2000 Oct; 63(3):193-8. PubMed ID: 11110053
[TBL] [Abstract] [Full Text] [Related]
18. Clear cell meningioma. A clinicopathologic study of a potentially aggressive variant of meningioma.
Zorludemir S; Scheithauer BW; Hirose T; Van Houten C; Miller G; Meyer FB
Am J Surg Pathol; 1995 May; 19(5):493-505. PubMed ID: 7726360
[TBL] [Abstract] [Full Text] [Related]
19. Immunohistochemical detection of female sex hormone receptors in meningiomas: correlation with clinical and histological features.
Brandis A; Mirzai S; Tatagiba M; Walter GF; Samii M; Ostertag H
Neurosurgery; 1993 Aug; 33(2):212-7; discussion 217-8. PubMed ID: 8367042
[TBL] [Abstract] [Full Text] [Related]
